EquityZen Growth Technology Fund LLC - Series 2144
Raised
$400K
Investors
22
Min Invest
$5,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2144 is a Delaware-based pooled investment fund filed by EquityZen Advisors on 2025-08-11, raising $400K from 22 investors under Rule 506(b) and Section 3(c)(1) with a $5K minimum investment. This is part of the EquityZen platform, which operates 1,889 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO fund vehicle follows the standard EquityZen series structure, using combined 506(b) and 3(c)(1) exemptions to remain outside Investment Company Act registration while limiting the investor base. The $5K minimum and 22-investor structure represent a retail-accessible entry point typical of the platform's secondary market SPV model.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
